LEXEO Therapeutics
Elena Bianchetti is an experienced Analytical Scientist at LEXEO Therapeutics, with a career spanning over a decade in various research roles. Prior positions include Associate Research Scientist and Lab Manager at Columbia University and Postdoctoral Research Scientist roles at both Columbia University and SISSA. Elena's academic background includes a Doctor of Philosophy in Neurobiology from SISSA, a Master’s Degree in Molecular Medicine from Università degli Studi di Trieste, and a Bachelor's Degree in Biotechnology from Università degli Studi di Milano. Elena also participated in research as a fellow in the European “REPLACES project” and has held research assistant positions at Lund University and Università degli Studi di Trieste.
LEXEO Therapeutics
LEXEO Therapeutics is a New York City-based, fully integrated biotechnology company currently headquartered at the Alexandria Center® for Life Science that aims to apply the transformational science of gene therapy to address some of the world’s most devastating genetic and acquired diseases. LEXEO Therapeutics’ pipeline consists of adeno-associated virus (AAV)-mediated therapies primarily developed at Weill Cornell Medicine’s Department of Genetic Medicine.